Lionco Pharmaceutical Group Co.,Ltd. (603669.SS)
CNY 4.37
(-1.58%)
CNY 4.37
(-1.58%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 235.93 Million CNY | -43.73% |
| 2022 | 360.26 Million CNY | -30.45% |
| 2021 | 518.01 Million CNY | -20.55% |
| 2020 | 652 Million CNY | -45.04% |
| 2019 | 1.18 Billion CNY | -6.47% |
| 2018 | 1.26 Billion CNY | 99.54% |
| 2017 | 635.65 Million CNY | 287.37% |
| 2016 | 164.09 Million CNY | -3.59% |
| 2015 | 170.2 Million CNY | -8.76% |
| 2014 | 186.54 Million CNY | 14.41% |
| 2013 | 163.05 Million CNY | 2.42% |
| 2012 | 159.2 Million CNY | 176.17% |
| 2011 | 57.64 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 39.15 Million CNY | -35.44% |
| 2024 Q1 | 60.64 Million CNY | 0.8% |
| 2024 Q3 | 62.63 Million CNY | 7.53% |
| 2023 Q1 | 65.53 Million CNY | -33.55% |
| 2023 FY | 202.72 Million CNY | -43.73% |
| 2023 Q4 | 60.16 Million CNY | 126.48% |
| 2023 Q3 | 26.56 Million CNY | -47.36% |
| 2023 Q2 | 50.46 Million CNY | -22.99% |
| 2022 Q4 | 98.61 Million CNY | -28.02% |
| 2022 Q3 | 137 Million CNY | 176.68% |
| 2022 Q2 | 49.51 Million CNY | -34.08% |
| 2022 Q1 | 75.12 Million CNY | 18.71% |
| 2022 FY | 360.26 Million CNY | -30.45% |
| 2021 Q1 | 187.91 Million CNY | 18.88% |
| 2021 Q4 | 63.27 Million CNY | -50.27% |
| 2021 Q3 | 127.24 Million CNY | -8.84% |
| 2021 Q2 | 139.57 Million CNY | -25.73% |
| 2021 FY | 518.01 Million CNY | -20.55% |
| 2020 Q3 | 169.07 Million CNY | -5.92% |
| 2020 FY | 652 Million CNY | -45.04% |
| 2020 Q2 | 179.72 Million CNY | 23.84% |
| 2020 Q1 | 145.12 Million CNY | -51.85% |
| 2020 Q4 | 158.08 Million CNY | -6.5% |
| 2019 Q4 | 301.42 Million CNY | 7.42% |
| 2019 Q2 | 326.33 Million CNY | 17.41% |
| 2019 Q1 | 277.95 Million CNY | -17.98% |
| 2019 Q3 | 280.6 Million CNY | -14.01% |
| 2019 FY | 1.18 Billion CNY | -6.47% |
| 2018 Q4 | 338.88 Million CNY | 16.81% |
| 2018 FY | 1.26 Billion CNY | 99.54% |
| 2018 Q3 | 290.12 Million CNY | -25.48% |
| 2018 Q2 | 389.33 Million CNY | 55.7% |
| 2018 Q1 | 250.05 Million CNY | -15.25% |
| 2017 Q1 | 51.52 Million CNY | -18.05% |
| 2017 Q2 | 121.92 Million CNY | 136.61% |
| 2017 Q3 | 167.15 Million CNY | 37.1% |
| 2017 Q4 | 295.04 Million CNY | 76.51% |
| 2017 FY | 635.65 Million CNY | 287.37% |
| 2016 Q1 | 31.83 Million CNY | -47.57% |
| 2016 FY | 164.09 Million CNY | -3.59% |
| 2016 Q2 | 33.02 Million CNY | 3.74% |
| 2016 Q3 | 36.35 Million CNY | 10.1% |
| 2016 Q4 | 62.87 Million CNY | 72.94% |
| 2015 Q4 | 60.71 Million CNY | 46.76% |
| 2015 Q3 | 41.37 Million CNY | 10.83% |
| 2015 Q2 | 37.33 Million CNY | 21.28% |
| 2015 Q1 | 30.78 Million CNY | -43.25% |
| 2015 FY | 170.2 Million CNY | -8.76% |
| 2014 Q2 | -7.58 Million CNY | 90.0% |
| 2014 FY | 186.54 Million CNY | 14.41% |
| 2014 Q4 | 54.24 Million CNY | 14.67% |
| 2014 Q1 | -75.89 Million CNY | 0.0% |
| 2014 Q3 | 47.3 Million CNY | 723.39% |
| 2013 FY | 163.05 Million CNY | 2.42% |
| 2012 FY | 159.2 Million CNY | 176.17% |
| 2011 FY | 57.64 Million CNY | 0.0% |